Breast cancer is subtyped based on molecular profiling for the expression of hormone receptors [progesterone receptor (PR), estrogen receptor alpha (ER)] and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.